Profil bibliographique

Elena Ongaro

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

113Publications signalées

2480Citations signalées

2Affiliations récentes

Institutions déclarées

National Cancer Institute Centro di Riferimento Oncologico

Domaines associés

Colorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsHER2/EGFR in Cancer Research

Publications récentes

Accès ouvert 2026 preprintOpenAlex

Probe-Based Confocal Laser Endomicroscopy During Immune Checkpoint Inhibitor Therapy: A Translational Framework Linking Intestinal Barrier Function, Microbiota, and Clinical Outcomes

Paola Spessotto, F. Orbosuè, Maurizio Mongiat, S. Maiero et autres

0 citationsPreprints.org

Accès ouvert 2026 articleOpenAlex

Prolonged response to combined BRAF and MEK inhibition in BRAF mutant colorectal cancer, a case report

Michela Guardascione, Monica Rizzetto, Luisa Foltran, Paola Di Nardo et autres

0 citationsFrontiers in Oncology

Accès ouvert 2026 reviewOpenAlex

Anti-Human Epidermal Growth Factor Receptor 2 therapies in metastatic colorectal cancer: a systematic review and meta-analysis

Simone Rota, Paola Di Nardo, E. Zottarelli, Fabiola Giudici et autres

0 citationsThe Oncologist

Accès ouvert 2026 articleOpenAlex

Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection

Letizia Procaccio, Guido Giordano, Federico Nichetti, Michele Milella³ et autres

0 citationsThe Oncologist

Accès ouvert 2026 articleOpenAlex

HLA-G alleles in Italian patients with locally advanced rectal cancer (LARC)

Lucia Scarabel, Erick C. Castelli, Michela Zorzi, Elena De Mattia et autres

0 citationsHuman Immunology

Accès ouvert 2026 articleOpenAlex

Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis

Paola Di Nardo, Marco de Scordilli, Fabiola Giudici, Debora Basile et autres

2 citationsThe Oncologist

Accès ouvert 2025 articleOpenAlex

Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial

D. Ciardiello, G. Martini, L.Boscolo Bielo, F. Pietrantonio et autres

7 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study

Carolina Sciortino, Federico Nichetti, Francesca Bergamo, Federica Palermo et autres

1 citationDigestive and Liver Disease

Accès ouvert 2025 articleOpenAlex

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy

Luca Boscolo Bielo, Stefania Napolitano, Antonio Avallone, F. Pietrantonio et autres

2 citationsESMO Open

Accès ouvert 2025 articleOpenAlex

A Diachronic Perspective on Evaluative Adverbs in German: The Case of leider

Elena Ongaro

0 citationsAnnali di Ca’ Foscari Serie occidentale

2025 articleOpenAlex

FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials

Carlotta Antoniotti, Federica Marmorino, Daniele Rossini, Hans‐Joachim Schmoll et autres

3 citationsEuropean Journal of Cancer

2025 articleOpenAlex

386TiP Gemcitabine and nab-paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The phase III PANThEON trial

Carolina Sciortino, F. Bergamo, Stefano Tamberi, C. Vivaldi et autres

0 citationsAnnals of Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.